References
- DeVault KR, Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch Intern Med 1995;13:2165–73.
- Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995;27:67–70.
- Ollyo JB, Monnier P, Fontolliet C, Savary M. The natural history, prevalence and incidence of reflux oesophagitis. Gullet 1993;3 Suppl:3–10.
- Lööf L, Götell P, Elfberg B. The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol 1993;28: 113–8.
- Sampliner RE. Effect of up to 3 years of high-dose lansoprazole on Barrett’s esophagus. Am J Gastroenterol 1994;10:1844–8.
- Hallerbäck B, Unge P, Carling L, Edwin B, Glise H, Havu N, et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 1994;107:1305–11.
- Armstrong D, Nicolet M, Monnier P, Chapuis G, Savary M, Blum AL. Maintenance therapy: is there still a place for antireflux surgery? World J Surg 1992;16:300–7.
- Klinkenberg-Knol EC, Festen HP, Jansen JBMJ, Lamers CB, Nelis F, Snel P, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994;3:161–7.
- Reynolds JC. Individualized acute treatment strategies for gastroesophageal reflux disease. Scand J Gastroenterol 1995;30 Suppl 213:17–24.
- Kieser C. Untersuchungen über die tödlichen Komplikationen von Hiatushernien. Gastroenterologia 1967;107:328–36.
- Brunnen PL, Karmody AM, Needham CD. Severe peptic oesophagitis. Gut 1969;10:831–83.
- Savary M, Miller G In: Handbook and atlas of endoscopy. Solothurn, Switzerland: Verlag Gassmann; 1983.
- Salo JA, Rantanen TK, Kivilaakso E. Gastroesophageal reflux disease (GERD) as cause of death: analysis of fatal cases under conservative treatment [abstract]. Gastroenterology 1997; Suppl:A1470.
- Rex JC, Andersen HA, Bartholomew LG, Cain JC. Esophageal hiatal hernia—a 10 year study of medically treated cases. JAMA 1961;3:271–4.
- Panos MZ, Walt RP, Stevenson C, Langman MJS. Rising death rate from non-malignant disease of the esophagus (NMOD) in England and Wales. Gut 1995;36:488–91.
- Katzka DA, Paoletti V, Leite L, Castell DO. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol 1996;10:2110–3.
- Zhu H, Pace F, Sangaletti O, Bianchi Porro G. Features of symptomatic gastroesophageal reflux in elderly patients. Scand J Gastroenterol 1993;28:235–8.
- Collen MJ, Abdulian JD, Chen YK. Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy. Am J Gastroenterol 1995;7:1053–7.
- Stein H, Barlow A, DeMeester T, Hinder R. Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 1992;216:35–43.
- Salo JA, Kivilaakso E. Role of luminal H+ in the pathogenesis of experimental esophagitis. Surgery 1982;92:61–8.
- Schirazi SS, Schulze K, Soper RT. Long-term follow-up for treatment of complicated chronic reflux esophagitis. Arch Surg 1987;4:548–51.
- Byrne WJ, Euler AR, Ashcraff E, Nash DG, Seibert JJ, Golladay ES. Gastroesophageal reflux in the severely retarded who vomit: criteria for and results of surgical intervention in twenty-two patients. Surgery 1982;4:548–51.
- Allen R, Rappaport W, Hixson L, Sampliner R, Case T, Fennerty B. Referral patterns and the results of antireflux operation in patients more than sixty years of age. Surg Gynecol Obstet 1991;11:359–62.